DEXCOM INC. DL-,001/ US2521311074 /
2024-06-14 8:08:22 AM | Chg. -2.84 | Volume | Bid3:55:58 PM | Ask3:55:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.96EUR | -2.61% | 0 Turnover: 0.00 |
106.74Bid Size: 380 | 107.12Ask Size: 380 | 42.03 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.